[
  {
    "ts": null,
    "headline": "Fulcrum: Next Set Of SCD Data Is Crucial For Continued Pipeline Advancement",
    "summary": "Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks. Click to find out why FULC is a Hold.",
    "url": "https://finnhub.io/api/news?id=abef70b46b659a4128f83cb3af188df4aade2854a033bfa14b123df143c13b8d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738951170,
      "headline": "Fulcrum: Next Set Of SCD Data Is Crucial For Continued Pipeline Advancement",
      "id": 132600240,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2192903839/image_2192903839.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks. Click to find out why FULC is a Hold.",
      "url": "https://finnhub.io/api/news?id=abef70b46b659a4128f83cb3af188df4aade2854a033bfa14b123df143c13b8d"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "summary": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=4ba119491e0376b1a269d0f8c3e106dd82369c31107d07dc06fa6d474705a9f7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738946220,
      "headline": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
      "id": 132607586,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=4ba119491e0376b1a269d0f8c3e106dd82369c31107d07dc06fa6d474705a9f7"
    }
  }
]